Holen Sie sich die Stockscreener-App
7.29
8.00%
0.54
Handel nachbörslich:
7.60
0.31
+4.25%
Schlusskurs vom Vortag:
$6.75
Offen:
$6.87
24-Stunden-Volumen:
67,823
Relative Volume:
0.11
Marktkapitalisierung:
$11.65M
Einnahmen:
$1.47M
Nettoeinkommen (Verlust:
$-97.61M
KGV:
-4.8926
EPS:
-1.49
Netto-Cashflow:
$-80.90M
1W Leistung:
+7.52%
1M Leistung:
-15.67%
6M Leistung:
-30.57%
1J Leistung:
-51.38%
1-Tages-Spanne:
$6.7001
$7.57
1-Wochen-Bereich:
$6.51
$7.57
52-Wochen-Spanne:
$3.8101
$37.50
Lyra Therapeutics Inc Stock (LYRA) Company Profile
Firmenname
Lyra Therapeutics Inc
Sektor
Branche
Telefon
617-373-4600
Adresse
480 ARSENAL WAY, WATERTOWN, MA
Vergleichen Sie LYRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LYRA
Lyra Therapeutics Inc
|
7.29 | 10.66M | 1.47M | -97.61M | -80.90M | -1.49 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-07 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-05-07 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-05-07 | Herabstufung | Jefferies | Buy → Hold |
| 2024-05-06 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-10-06 | Fortgesetzt | BTIG Research | Buy |
| 2023-08-31 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-05-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-05-26 | Eingeleitet | BTIG Research | Buy |
| 2020-05-26 | Eingeleitet | BofA/Merrill | Buy |
| 2020-05-26 | Eingeleitet | Jefferies | Buy |
| 2020-05-26 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Lyra Therapeutics Inc Aktie (LYRA) Neueste Nachrichten
Key metrics from Lyra Therapeutics Inc.’s quarterly dataWeekly Investment Summary & Expert Approved Trade Ideas - Newser
Chart based exit strategy for Lyra Therapeutics Inc.2025 Big Picture & High Conviction Buy Zone Picks - Newser
Why Lyra Therapeutics Inc. is moving todayMarket Sentiment Summary & Fast Momentum Stock Entry Tips - Newser
Developing predictive dashboards with Lyra Therapeutics Inc. dataShare Buyback & Free Reliable Trade Execution Plans - Newser
Lyra Therapeutics 2025 Q2 Earnings Significant Loss Reduction - AInvest
Lyra Therapeutics Reports Q2 2025 Financial Results - TipRanks
Lyra Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Risk vs reward if holding onto Lyra Therapeutics Inc.Market Risk Analysis & Reliable Price Action Trade Plans - Newser
Building trade automation scripts for Lyra Therapeutics Inc.Free Early Entry Tips With Low Risk Zone - Newser
Lyra Therapeutics Posts 85% Q2 Loss Drop - Nasdaq
Can trapped investors hope for a rebound in Lyra Therapeutics Inc.Historical Stock Summary and ROI Review - Newser
Lyra Therapeutics, Inc. (LYRA) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Should you wait for a breakout in Lyra Therapeutics Inc.Free Access to Smart Investment Tips - Newser
Lyra Therapeutics: Navigating Financial Challenges on the Road to Profitability - AInvest
Lyra Therapeutics Q2 rev. up 9% YoY, cash runway extended to 3Q 2026. - AInvest
LYRA THERAPEUTICS Earnings Results: $LYRA Reports Quarterly Earnings - Quiver Quantitative
Lyra Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Using economic indicators to assess Lyra Therapeutics Inc. potentialInstitutional Holding Behavior Pattern Analysis - Newser
Lyra Therapeutics reports Q2 EPS ($5.51), consensus ($4.78) - TipRanks
Lyra's Nasal Implant Shows Promise in Phase 3 Trial, Extends Cash Runway Through 2026 - Stock Titan
Real time breakdown of Lyra Therapeutics Inc. stock performanceSwing Trade Signal and Price Prediction - Newser
What makes Lyra Therapeutics Inc. stock price move sharplyPortfolio Allocation Strategy for Stability - Newser
Understanding Lyra Therapeutics Inc.’s price movementOversold Reversal Picks with Buy Zone - Newser
Sentiment analysis tools applied to Lyra Therapeutics Inc.Trade Alert System with Volume Analysis - Newser
Custom strategy builders for tracking Lyra Therapeutics Inc.Free Daily Profit Focused Stock Screener - Newser
Is Lyra Therapeutics Inc. stock reversal real or fakeBuy Strategy Review With Performance Summary - Newser
What earnings revisions data tells us about Lyra Therapeutics Inc.Smart Entry Watchlist with Daily Analysis - Newser
Chart overlay techniques for tracking Lyra Therapeutics Inc.Free Low Risk Picks for Daily Trading - Newser
Lyra Therapeutics Inc. stock trendline breakdownDaily Swing Candidate Analysis with Chart Patterns - Newser
RSI + MACD Show Convergence for Lyra Therapeutics Inc.Scalable Portfolio Growth Suggestions Released - metal.it
Lyra Therapeutics (LYRA) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Published on: 2025-08-11 02:07:15 - Newser
Will Lyra Therapeutics Inc. rebound enough to break evenFree Short Term Trading Opportunity Watch - Newser
Predicting Lyra Therapeutics Inc. trend using moving averagesFree AI Powered High Return Stock Calls - Newser
Is it time to cut losses on Lyra Therapeutics Inc.Free AI-Powered Trade Planning with Indicators - Newser
Why Lyra Therapeutics Inc. stock attracts strong analyst attentionSafe Momentum Strategy With Trend Analysis - Newser
How to use a screener to detect Lyra Therapeutics Inc. breakoutsWeekly High Conviction Trade Setup Analysis - Newser
Is Lyra Therapeutics Inc. stock poised for growthSmart Risk Strategy with Entry Optimization - Newser
Lyra Therapeutics Inc expected to post a loss of $6.02 a shareEarnings Preview - TradingView
Published on: 2025-08-06 20:20:47 - Newser
What to do if you’re stuck in Lyra Therapeutics Inc.Free AI Based High Gain Watchlist Scanner - Newser
Real time alert setup for Lyra Therapeutics Inc. performanceFree Market Momentum and Signal Alerts - Newser
Is it the right time to buy Lyra Therapeutics Inc. stockGet expert analysis on top stock picks - Jammu Links News
Real time scanner hits for Lyra Therapeutics Inc. explainedHigh Yield Watchlist with Filtered Picks - Newser
Is Lyra Therapeutics Inc. stock overvalued or undervaluedInvest smarter with actionable trading signals - Jammu Links News
Should I hold or sell Lyra Therapeutics Inc. stock in 2025Free Investment Risk Control - Jammu Links News
What catalysts could drive Lyra Therapeutics Inc. stock higher in 2025Free Predictions - Jammu Links News
Finanzdaten der Lyra Therapeutics Inc-Aktie (LYRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lyra Therapeutics Inc-Aktie (LYRA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Cavalier Jason | Chief Financial Officer |
Jul 10 '25 |
Sale |
8.91 |
684 |
6,094 |
519,316 |
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):